Heritage Pharma launches generic Provigil
Specialty generic company Heritage Pharmaceuticals has introduced its generic Provigil (modafinil tablets). The East Brunswick, N.J.-based company’s generic is indicated to treat such sleep disorders as narcolepsy, shift work sleep disorder and obstructive sleep apnea.
Heritage Pharma’s generic Provigil will be available in 100- and 200-mg dosage strength tablets. The product enters a market whose annual sales totaled roughly $112 million for the 12 months ended May 2018, according to IQVIA data.
Heritage Pharma’s generic Provigil will be available in 100- and 200-mg dosage strength tablets. The product enters a market whose annual sales totaled roughly $112 million for the 12 months ended May 2018, according to IQVIA data.